Mirum Pharmaceuticals, Inc.
MIRM
$96.55
$3.914.22%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 73.43% | 58.50% | 46.35% | 51.22% | 46.18% |
| Total Depreciation and Amortization | 2.60% | 5.02% | 23.10% | 58.47% | 118.20% |
| Total Amortization of Deferred Charges | 4.70% | 4.56% | 4.23% | 9.73% | 48.70% |
| Total Other Non-Cash Items | 44.73% | 18.42% | 19.98% | -41.12% | -49.49% |
| Change in Net Operating Assets | -187.27% | -143.92% | -267.27% | -272.03% | 217.53% |
| Cash from Operations | 440.70% | 3,748.33% | 138.39% | 81.47% | 114.55% |
| Capital Expenditure | 3.93% | 61.56% | 53.54% | -1,160.49% | -811.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 74.20% | 73.91% | 9.51% | -233.85% | -184.35% |
| Cash from Investing | 73.42% | 73.78% | 84.42% | 20.85% | 15.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 126.80% | 153.06% | -88.86% | -89.25% | -92.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 126.80% | 158.09% | -88.85% | -92.96% | -94.74% |
| Foreign Exchange rate Adjustments | 348.42% | 1,084.74% | 1,034.27% | -70.67% | -875.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 218.67% | 174.19% | 92.32% | -159.05% | -140.04% |